Navigate your drug discovery and clinical trials with a partner built for enterprise scale. Operating out of our CAP-accredited laboratory, Microbiome Insights provides the high-volume sequencing capacity, rigorous quality management, and regulatory compliance required to support FDA submissions and advance complex pipelines.
GlobalCROs | PharmaR&D | Clinical Trial Coordinators
From comfortable and compliant sample collection through advanced bioinformatics interpretation, our team delivers optimized workflows designed to accommodate patient sensitivities and study objectives.
Establish highly accurate baseline microbiome profiles across diverse global cohorts prior to therapeutic intervention.
Track microbial signatures associated with specific chronic conditions, inflammatory pathways, or targeted therapeutic indications.
Identify microbiome-based biomarkers to predict therapeutic responders vs. non-responders before or during clinical trials.
Evaluate how your biotherapeutic, small molecule, or live biotherapeutic product (LBP) alters the host microbial ecosystem.
Track microbial signatures associated with toxicity, drug-induced gut dysbiosis, or secondary infections to protect participant safety.
Monitor microbial shifts over time in multi-center clinical trials with strict timeline demands and high sample volumes.
Best for: Cost-effective, high-throughput taxonomic profiling and broad bacterial/fungal community mapping across large cohorts.
Key applications:
Best for: High-resolution, strain-level taxonomic profiling, functional gene profiling, and antimicrobial resistance (AMR) detection.
Key applications:
Best for: Studies requiring quantification beyond relative abundance -whether quantifying specific microbial targets or measuring the functional metabolic outputs of the microbial community.
Key applications:
Extraction Method: Validated, high-throughput DNA extraction protocols optimized for diverse human samples (including fecal, skin, oral, and tissue matrices) using automated liquid-handling platforms to eliminate human error and maximize reproducibility.
Physical Protection: All samples are processed within our CAP-accredited facility under strict contamination-free workflows, using biosafety cabinets and unidirectional airflows to isolate true biological signals from background environmental noise.
Optimization Strategy: Rigorous initial QC checkpoints, including fluorometric and qPCR quantification, ensure that low-biomass or challenging sample types are properly normalized prior to sequencing, helping ensure consistent, high-quality data yields.
10 Years of Clinical Trial Expertise:
With a decade of specialized experience, we have supported complex multi-center clinical trials across global cohorts. We understand the rigorous documentation, strict chain-of-custody protocols, and critical timeline demands that pharmaceutical sponsors require to keep their programs on track.
High-Volume, Scalable Capacity:
Our state-of-the-art laboratory is purpose-built for industrial, high-throughput processing. Whether you are running an early-stage discovery cohort or an expansive Phase III trial with thousands of longitudinal samples, our robust capacity ensures rapid and highly predictable turnaround times without ever compromising data integrity.
Flexible Custom Bioinformatic Pipelines:
We don’t force your research into rigid, off-the-shelf templates. Our team is highly flexible with novel drug actions (NDAs), mapping complex therapeutic responses, and developing custom analysis pipelines tailored specifically to your unique mechanism of action (MoA) and clinical endpoints.
Publication-Ready, Regulatory-Grade Deliverables:
Data security and regulatory alignment are baked into every step of our workflow. We generate comprehensive, audit-ready data packages designed to seamlessly integrate into your IND/NDA filings and FDA regulatory submissions, alongside polished, publication-ready visualizations for peer-reviewed journals.
Privacy & Compliance Note:
We maintain secure data architecture with double-blinded labeling and de-identified clinical metadata handling, ensuring strict compliance with trial protocols and HIPAA/GDPR standards.
Our experts will guide you through sample collection, project design, sequencing strategy, and data interpretation to ensure reliable, publication-quality results.
How should I collect and ship these samples?
We provide validated, room-temperature stable collection kits that are ideal for decentralized clinical trial sites, eliminating the need for cold-chain shipping. Alternatively, we accept frozen unpreserved samples shipped on dry ice with strict chain-of-custody tracking.
Why is clinical microbiome analysis particularly challenging?
Clinical trials demand extreme reproducibility, strict chain-of-custody, and audit-ready data. Standard academic pipelines often lack the rigorous quality control, standardized SOPs, and CAP-accredited environment required to survive external audits and FDA submissions
Can we detect specific therapeutic mechanisms of action (MoA)?
Yes. Our bioinformatics team specializes in creating custom analysis pipelines that track how your therapeutic or small molecule alters the microbial ecosystem, helping you map therapeutic responses to clinical endpoints.
What is the typical turnaround time (TAT)?
Backed by our industrial-scale throughput, we deliver reliable, high-quality results within a standard turnaround time of 4 to 6 weeks. .
